Cripto-1: a Multifunctional Modulator During Embryogenesis and Oncogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cripto-1 As a Potential Target of Cancer Stem Cells for Immunotherapy
cancers Review Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy Hiroko Ishii 1 , Said M. Afify 2,3 , Ghmkin Hassan 2 , David S. Salomon 4 and Masaharu Seno 2,* 1 GSP Enterprise, Inc., 1-4-38 12F Minato-machi, Naniwa-ku, Osaka 556-0017, Japan; [email protected] 2 Laboratory of Nano-Biotechnology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama 700-8530, Japan; saidafi[email protected] (S.M.A.); [email protected] (G.H.) 3 Division of Biochemistry, Chemistry Department, Faculty of Science, Menoufia University, Shebin ElKoum Menoufia 32511, Egypt 4 Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; [email protected] * Correspondence: [email protected]; Tel.: +81-86-251-8216 Simple Summary: Cancer immunotherapy is gaining attention as a potential fourth treatment following surgery, chemotherapy, and radiation therapy. Cancer stem cells have recently been recognized and validated as a key target for cancer treatment. Cripto-1, which is a GPI-anchored membrane-bound protein that functions as a co-receptor of Nodal, is a marker of cancer stem cells. Since Nodal is a member of the TGF-β family, which performs an important role in stem cells and cancer stem cells, the inhibition of Cripto-1 could be a strategy by which to block Nodal signaling and thereby suppress cancer stem cells. We propose that Cripto-1 may be a novel target for cancer immunotherapy. Citation: Ishii, H.; Afify, S.M.; Hassan, G.; Salomon, D.S.; Seno, M. -
Reproductionresearch
REPRODUCTIONRESEARCH Bone morphogenetic protein 15 and fibroblast growth factor 10 enhance cumulus expansion, glucose uptake, and expression of genes in the ovulatory cascade during in vitro maturation of bovine cumulus–oocyte complexes Ester S Caixeta, Melanie L Sutton-McDowall1, Robert B Gilchrist1, Jeremy G Thompson1, Christopher A Price2, Mariana F Machado, Paula F Lima and Jose´ Buratini Departamento de Fisiologia, Instituto de Biocieˆncias, Universidade Estadual Paulista, Rubia˜o Junior, Botucatu, Sa˜o Paulo 18618-970, Brazil, 1The Robinson Institute, Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South Australia 5005, Australia and 2Centre de Recherche en Reproduction Animale, Faculte´ de Me´decine Ve´te´rinaire, Universite´ de Montre´al, St-Hyacinthe, Quebec, Canada J2S 7C6 Correspondence should be addressed to J Buratini; Email: [email protected] Abstract Oocyte-secreted factors (OSFs) regulate differentiation of cumulus cells and are of pivotal relevance for fertility. Bone morphogenetic protein 15 (BMP15) and fibroblast growth factor 10 (FGF10) are OSFs and enhance oocyte competence by unknown mechanisms. We tested the hypothesis that BMP15 and FGF10, alone or combined in the maturation medium, enhance cumulus expansion and expression of genes in the preovulatory cascade and regulate glucose metabolism favouring hyaluronic acid production in bovine cumulus–oocyte complexes (COCs). BMP15 or FGF10 increased the percentage of fully expanded COCs, but the combination did not further stimulate it. BMP15 increased cumulus cell levels of mRNA encoding a disintegrin and metalloprotease 10 (ADAM10), ADAM17, amphiregulin (AREG), and epiregulin (EREG) at 12 h of culture and of prostaglandin (PG)-endoperoxide synthase 2 (PTGS2), pentraxin 3 (PTX3) and tumor necrosis factor alpha-induced protein 6 (TNFAIP6 (TSG6)) at 22 h of culture. -
Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Hippocampus: Modulation of Expression by Seizures and Anti- Excitotoxic Action
The Journal of Neuroscience, January 1, 1999, 19(1):133–146 Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Hippocampus: Modulation of Expression by Seizures and Anti- Excitotoxic Action Lisa A. Opanashuk,1 Robert J. Mark,1,2 Julie Porter,1 Deborah Damm,3 Mark P. Mattson,1,2 and Kim B. Seroogy1 1Department of Anatomy and Neurobiology and 2Sanders-Brown Research Center on Aging, University of Kentucky, Lexington, Kentucky 40536, and 3Scios Inc., Mountain View, California 94043 The expression of heparin-binding epidermal growth factor-like around hippocampal pyramidal CA3 and CA1 neurons. At 48 hr growth factor (HB-EGF), an EGF receptor ligand, was investi- after kainate treatment, HB-EGF mRNA remained elevated in gated in rat forebrain under basal conditions and after kainate- vulnerable brain regions of the hippocampus and amygdaloid induced excitotoxic seizures. In addition, a potential neuropro- complex. Western blot analysis revealed increased levels of tective role for HB-EGF was assessed in hippocampal cultures. HB-EGF protein in the hippocampus after kainate administra- In situ hybridization analysis of HB-EGF mRNA in developing tion, with a peak at 24 hr. Pretreatment of embryonic hippocam- rat hippocampus revealed its expression in all principle cell pal cell cultures with HB-EGF protected neurons against kai- 21 layers of hippocampus from birth to postnatal day (P) 7, nate toxicity. The kainate-induced elevation of [Ca ]i in whereas from P14 through adulthood, expression decreased in hippocampal neurons was not altered in cultures pretreated the pyramidal cell layer versus the dentate gyrus granule cells. with HB-EGF, suggesting an excitoprotective mechanism dif- After kainate-induced excitotoxic seizures, levels of HB-EGF ferent from that of previously characterized excitoprotective mRNA increased markedly in the hippocampus, as well as in growth factors. -
Regulation of Mitogen-Activated Protein Kinase and Phosphoinositide 3-Kinase Signaling by Wild-Type and Oncogenic Ras
REGULATION OF MITOGEN-ACTIVATED PROTEIN KINASE AND PHOSPHOINOSITIDE 3-KINASE SIGNALING BY WILD-TYPE AND ONCOGENIC RAS by Amy Young DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biomedical Sciences in the GRADUATE DIVISION of the UNIVERSITY OF CALIFORNIA, SAN I RANCISCO Copyright 2011 by Amy Young ii ACKNOWLEDGEMENTS It is hard to believe that my graduate career has finally come to an end. The work presented here could not have been possible without the support and generosity of the many people I have had the privilege to work with during my time at UCSF. First and foremost, I would like to thank my graduate advisor Frank McCormick for his guidance and support during my time as a student in his lab. I have learned a tremendous amount while training in the lab, and I sincerely appreciate Frank’s enthusiasm for science, his optimism for our projects, and the freedom he gives us to pursue our scientific research. I also want to thank Frank for being a very kind and generous mentor - I have been incredibly lucky to have been a member of the McCormick lab, and I value all of the opportunities and experiences I have had over the past several years. I would like to thank the members of my thesis committee, Allan Balmain and David Stokoe, for their advice and encouragement. I appreciate the time they sacrificed to provide feedback on my projects, and I am honored to have trained under some of the brightest minds in the field of Ras signaling. -
Supplementary Materials
Supplementary Materials + - NUMB E2F2 PCBP2 CDKN1B MTOR AKT3 HOXA9 HNRNPA1 HNRNPA2B1 HNRNPA2B1 HNRNPK HNRNPA3 PCBP2 AICDA FLT3 SLAMF1 BIC CD34 TAL1 SPI1 GATA1 CD48 PIK3CG RUNX1 PIK3CD SLAMF1 CDKN2B CDKN2A CD34 RUNX1 E2F3 KMT2A RUNX1 T MIXL1 +++ +++ ++++ ++++ +++ 0 0 0 0 hematopoietic potential H1 H1 PB7 PB6 PB6 PB6.1 PB6.1 PB12.1 PB12.1 Figure S1. Unsupervised hierarchical clustering of hPSC-derived EBs according to the mRNA expression of hematopoietic lineage genes (microarray analysis). Hematopoietic-competent cells (H1, PB6.1, PB7) were separated from hematopoietic-deficient ones (PB6, PB12.1). In this experiment, all hPSCs were tested in duplicate, except PB7. Genes under-expressed or over-expressed in blood-deficient hPSCs are indicated in blue and red respectively (related to Table S1). 1 C) Mesoderm B) Endoderm + - KDR HAND1 GATA6 MEF2C DKK1 MSX1 GATA4 WNT3A GATA4 COL2A1 HNF1B ZFPM2 A) Ectoderm GATA4 GATA4 GSC GATA4 T ISL1 NCAM1 FOXH1 NCAM1 MESP1 CER1 WNT3A MIXL1 GATA4 PAX6 CDX2 T PAX6 SOX17 HBB NES GATA6 WT1 SOX1 FN1 ACTC1 ZIC1 FOXA2 MYF5 ZIC1 CXCR4 TBX5 PAX6 NCAM1 TBX20 PAX6 KRT18 DDX4 TUBB3 EPCAM TBX5 SOX2 KRT18 NKX2-5 NES AFP COL1A1 +++ +++ 0 0 0 0 ++++ +++ ++++ +++ +++ ++++ +++ ++++ 0 0 0 0 +++ +++ ++++ +++ ++++ 0 0 0 0 hematopoietic potential H1 H1 H1 H1 H1 H1 PB6 PB6 PB7 PB7 PB6 PB6 PB7 PB6 PB6 PB6.1 PB6.1 PB6.1 PB6.1 PB6.1 PB6.1 PB12.1 PB12.1 PB12.1 PB12.1 PB12.1 PB12.1 Figure S2. Unsupervised hierarchical clustering of hPSC-derived EBs according to the mRNA expression of germ layer differentiation genes (microarray analysis) Selected ectoderm (A), endoderm (B) and mesoderm (C) related genes differentially expressed between hematopoietic-competent (H1, PB6.1, PB7) and -deficient cells (PB6, PB12.1) are shown (related to Table S1). -
Cripto Regulates Skeletal Muscle Regeneration and Modulates Satellite Cell Determination by Antagonizing Myostatin
Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin. Ombretta Guardiola, Peggy Lafuste, Silvia Brunelli, Salvatore Iaconis, Thierry Touvier, Philippos Mourikis, Katrien de Bock, Enza Lonardo, Gennaro Andolfi, Ann Bouché, et al. To cite this version: Ombretta Guardiola, Peggy Lafuste, Silvia Brunelli, Salvatore Iaconis, Thierry Touvier, et al.. Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myo- statin.. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2012, 109 (47), pp.E3231-40. 10.1073/pnas.1204017109. inserm-00769969 HAL Id: inserm-00769969 https://www.hal.inserm.fr/inserm-00769969 Submitted on 5 May 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 1 Classification: Biological Sciences, Developmental Biology; 2 3 CRIPTO REGULATES SKELETAL MUSCLE REGENERATION AND MODULATES SATELLITE 4 CELL DETERMINATION BY ANTAGONIZING MYOSTATIN 5 6 Ombretta Guardiola1,2*, Peggy Lafuste3,4,5,*, Silvia Brunelli6,7,§, Salvatore Iaconis1,2,§, 7 Thierry Touvier8, Philippos Mourikis9, Katrien De Bock3,4, Enza Lonardo1,2, Gennaro 8 Andolfi1,2, Ann Bouché3, Giovanna L. Liguori2, Michael M. Shen10, Shahragim Tajbakhsh9, 9 Giulio Cossu11, Peter Carmeliet3,4,‡ and Gabriella Minchiotti1,2‡^ 10 1. -
Ecsit Is Required for Bmp Signaling and Mesoderm Formation During Mouse Embryogenesis
Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis Changchun Xiao,1 Jae-hyuck Shim,1,6 Michael Klüppel,5,6 Samuel Shao-Min Zhang,3,6 Chen Dong,1,7 Richard A. Flavell,1 Xin-Yuan Fu,3 Jeffrey L. Wrana,5 Brigid L.M. Hogan,4 and Sankar Ghosh1,2,8 1Section of Immunobiology, 2Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, and 3Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA; 4Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA; 5Programme in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada Bone morphogenetic proteins (Bmps) are members of the transforming growth factor  (TGF) superfamily that play critical roles during mouse embryogenesis. Signaling by Bmp receptors is mediated mainly by Smad proteins. In this study, we show that a targeted null mutation of Ecsit, encoding a signaling intermediate of the Toll pathway, leads to reduced cell proliferation, altered epiblast patterning, impairment of mesoderm formation, and embryonic lethality at embryonic day 7.5 (E7.5), phenotypes that mimic the Bmp receptor type1a (Bmpr1a) null mutant. In addition, specific Bmp target gene expression is abolished in the absence of Ecsit. Biochemical analysis demonstrates that Ecsit associates constitutively with Smad4 and associates with Smad1 in a Bmp-inducible manner. Together with Smad1 and Smad4, Ecsit binds to the promoter of specific Bmp target genes. Finally, knock-down of Ecsit with Ecsit-specific short hairpin RNA inhibits both Bmp and Toll signaling. -
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................ -
Cripto Regulates Skeletal Muscle Regeneration and Modulates
Cripto regulates skeletal muscle regeneration and PNAS PLUS modulates satellite cell determination by antagonizing myostatin Ombretta Guardiolaa,b,1, Peggy Lafustec,d,e,1, Silvia Brunellif,g,2, Salvatore Iaconisa,b,2, Thierry Touvierh, Philippos Mourikisi, Katrien De Bockc,d, Enza Lonardoa,b, Gennaro Andolfia,b, Ann Bouchéc, Giovanna L. Liguorib, Michael M. Shenj, Shahragim Tajbakhshi, Giulio Cossuk, Peter Carmelietc,d,3, and Gabriella Minchiottia,b,3,4 aStem Cell Fate Laboratory, Institute of Genetics and Biophysics “Adriano Buzzati-Traverso,” Consiglio Nazionale delle Ricerche, 80131 Naples, Italy; bInstitute of Genetics and Biophysics “Adriano Buzzati-Traverso,” Consiglio Nazionale delle Ricerche, 80131 Naples, Italy; cLaboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, Flemish Institute of Biotechnology, 3000 Leuven, Belgium; dLaboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, Department of Oncology, University of Leuven, 3000 Leuven, Belgium; eInstitut National de la Santé et de la Recherche Médicale, U955, Team 10 “Cell Interactions in the Neuromuscular System,” University Paris Est Creteil, F-94000 Creteil, France; fDivision of Regenerative Medicine, San Raffaele Scientific Institute, 20132 Milan, Italy; gDepartment of Experimental Medicine, University of Milano-Bicocca, 20052 Monza, Italy; hEugenio Medea Scientific Institute, 23842 Bosisio Parini, Italy; iStem Cells and Development Unit, Institut Pasteur, Centre National de la Recherche Scientifique, Unité de Recherche Associée, 2578 -
Human Amphiregulin Quantikine ELISA
Quantikine® ELISA Human Amphiregulin Immunoassay Catalog Number DAR00 For the quantitative determination of human Amphiregulin concentrations in cell culture supernates, cell lysates, serum, plasma, saliva, and urine. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION .....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ...................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE .................................................................................................................................2 TECHNICAL HINTS .................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ...................................................................................................3 OTHER SUPPLIES REQUIRED .............................................................................................................................................3 PRECAUTIONS .........................................................................................................................................................................4 -
Defects in GPI Biosynthesis Perturb Cripto Signaling During Forebrain Development in Two New Mouse Models of Holoprosencephaly
874 Research Article Defects in GPI biosynthesis perturb Cripto signaling during forebrain development in two new mouse models of holoprosencephaly David M. McKean and Lee Niswander* HHMI, Department of Pediatrics, Cell Biology, Stem Cells and Development Graduate Program, and Children’s Hospital Colorado, University of Colorado Anschutz Medical Campus Aurora, CO 80045, USA *Author for correspondence ([email protected]) Biology Open 1, 874–883 doi: 10.1242/bio.20121982 Received 16th May 2012 Accepted 6th June 2012 Summary Holoprosencephaly is the most common forebrain defect in involved in TGFb signaling, and we show that TGFb signaling is humans. We describe two novel mouse mutants that display a reduced both in vitro and in vivo. This work demonstrates the holoprosencephaly-like phenotype. Both mutations disrupt genes importance of the GPI anchor in normal forebrain development in the glycerophosphatidyl inositol (GPI) biosynthesis pathway: and suggests that GPI biosynthesis genes should be screened for gonzo disrupts Pign and beaker disrupts Pgap1. GPI anchors association with human holoprosencephaly. normally target and anchor a diverse group of proteins to lipid raft domains. Mechanistically we show that GPI anchored ß 2012. Published by The Company of Biologists Ltd. This is proteins are mislocalized in GPI biosynthesis mutants. an Open Access article distributed under the terms of the Disruption of the GPI-anchored protein Cripto (mouse) and Creative Commons Attribution Non-Commercial Share Alike TDGF1 (human ortholog) have been shown to result in License (http://creativecommons.org/licenses/by-nc-sa/3.0). holoprosencephaly, leading to our hypothesis that Cripto is the key GPI anchored protein whose altered function results in an Key words: Holoprosencephaly (HPE), forebrain, HPE-like phenotype. -
Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in Era-Positive Breast Cancer Esther A
Published OnlineFirst November 2, 2015; DOI: 10.1158/0008-5472.CAN-15-0709 Cancer Molecular and Cellular Pathobiology Research Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERa-Positive Breast Cancer Esther A. Peterson1, Edmund C. Jenkins1, Kristopher A. Lofgren1,2, Natasha Chandiramani1, Hui Liu1, Evelyn Aranda1, Maryia Barnett1,and Paraic A. Kenny1,2 Abstract Estrogen stimulation promotes epithelial cell proliferation in enriched in ERa-positive humanbreast tumor cells and required for estrogen receptor (ERa)-positive breast cancer. Many ERa target estrogen-dependent growth of MCF7 tumor xenografts. Further- genes have been enumerated, but the identities of the key effectors more, amphiregulin levels were suppressed in patients treated with mediating the estrogen signal remain obscure. During mouse endocrine therapy. Suppression of EGF receptor signaling appeared mammary gland development, the estrogen growth factor receptor necessary for the therapeutic response in this setting. Our (EGFR) ligand amphiregulin acts as an important stage-specific findings implicate amphiregulin as a critical mediator of the effector of estrogen signaling. In this study, we investigated the role estrogen response in ERa-positive breast cancer, emphasizing the of amphiregulin in breast cancer cell proliferation using human importance of EGF receptor signaling in breast tumor pathogenesis tissue samples and tumor xenografts in mice. Amphiregulin was and therapeutic response. Cancer Res; 75(22); 1–9. Ó2015 AACR. Introduction receptor (EGFR), is induced during the proliferative phase of mouse pubertal mammary growth, where it is a direct transcriptional Estrogen is an essential hormone for mammary gland devel- target of ERa (6, 7). Mammary glands of amphiregulin knockout opment and is a key driver of proliferation during the develop- þ mice have a striking defect in pubertal epithelial outgrowth but ment of estrogen receptor–positive (ERa ) breast tumors.